Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Just the facts, please

Nature Biotechnology volume 31, pages 1075–1076 (2013)Cite this article

Subjects

To the Editor:

As co-founder and CEO of 23andMe, I was disturbed to read a Correspondence from Geneyouin founder and CEO Ruslan Dorfman in the September issue1 that includes assertions and innuendo regarding my company that are false and misleading. I would like to correct these errors and set the record straight for Nature Biotechnology's readership.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dorfman, R. Nat. Biotechnol. 31, 785–786 (2013).

    Article  CAS  Google Scholar 

  2. Tung, J.Y. et al. J. Invest. Dermatol. 133, 2628–2631 (2013).

    Article  CAS  Google Scholar 

  3. Hinds, D.A. et al. Nat. Genet. 45, 907–911 (2013).

    Article  CAS  Google Scholar 

  4. Pichler, I. et al. PLoS Med. 10, e1001462 (2013).

    Article  CAS  Google Scholar 

  5. Kiefer, A.K. et al. PLoS Genet. 9, e1003299 (2013).

    Article  CAS  Google Scholar 

  6. Francke, U. et al. PeerJ. 1, e8 (2013).

    Article  Google Scholar 

  7. Eriksson, N. et al. Flavour 1, 22 (2012).

    Article  Google Scholar 

  8. Heilmann, S. et al. J. Invest. Dermatol. 133, 2628–2631 (2013).

    Article  Google Scholar 

  9. Do, C.B., Hinds, D.A., Francke, U. & Eriksson, N. PLoS Genet. 8, e1002973 (2012).

    Article  CAS  Google Scholar 

  10. Eriksson, N. et al. BMC Med. Genet. 13, 53 (2012).

    Article  CAS  Google Scholar 

  11. Li, R. et al. PLoS Genet. 8, e1002746 (2012).

    Article  CAS  Google Scholar 

  12. Henn, B.M. et al. PLoS ONE 7, e34267 (2012).

    Article  CAS  Google Scholar 

  13. Eriksson, N. PLoS ONE 7, e34442 (2012).

    Article  CAS  Google Scholar 

  14. Lill, C.M. et al. PLoS Genet. 8, e1002548 (2012).

    Article  CAS  Google Scholar 

  15. Tung, J.Y. et al. PLoS ONE 6, e23473 (2011).

    Article  CAS  Google Scholar 

  16. Do, C.B. et al. PLoS Genet. 7, e1002141 (2011).

    Article  CAS  Google Scholar 

  17. Eriksson, N. et al. PLoS Genet. 6, e1000993 (2010).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anne Wojcicki is at 23andMe Inc., Mountain View, California, USA.,

    Anne Wojcicki

Authors
  1. Anne Wojcicki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Wojcicki.

Ethics declarations

Competing interests

Ann Wojcicki is co-founder and CEO of 23andMe and thus is an employee with stock options/equity in the company.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wojcicki, A. Just the facts, please. Nat Biotechnol 31, 1075–1076 (2013). https://doi.org/10.1038/nbt.2771

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2771

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing